Home Vaccinex

Vaccinex

In operation
IPO
Targeted Biologic Therapies Developer

Basic Information

Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapies to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative disorders, and autoimmune diseases, currently undergoing active clinical trials in non-small-scale clinical studies.
Vaccinex, Inc.
NewYork,United States of America
15~50 people
January 01, 1997
info@vaccinex.com